Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;37(8):770-780.
doi: 10.1007/s10875-017-0443-1. Epub 2017 Sep 21.

Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis

Sandra Ammann  1   2 , Kai Lehmberg  3 , Udo Zur Stadt  4 , Christian Klemann  1 , Sebastian F N Bode  1   5 , Carsten Speckmann  1   5 , Gritta Janka  3 , Katharina Wustrau  3 , Mirzokhid Rakhmanov  1   6 , Ilka Fuchs  1 , Hans C Hennies  7   8   9 , Stephan Ehl  10   11 ; HLH study of the GPOH
Collaborators, Affiliations

Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis

Sandra Ammann et al. J Clin Immunol. 2017 Nov.

Abstract

We report our experience in using flow cytometry-based immunological screening prospectively as a decision tool for the use of genetic studies in the diagnostic approach to patients with hemophagocytic lymphohistiocytosis (HLH). We restricted genetic analysis largely to patients with abnormal immunological screening, but included whole exome sequencing (WES) for those with normal findings upon Sanger sequencing. Among 290 children with suspected HLH analyzed between 2010 and 2014 (including 17 affected, but asymptomatic siblings), 87/162 patients with "full" HLH and 79/111 patients with "incomplete/atypical" HLH had normal immunological screening results. In 10 patients, degranulation could not be tested. Among the 166 patients with normal screening, genetic analysis was not performed in 107 (all with uneventful follow-up), while 154 single gene tests by Sanger sequencing in the remaining 59 patients only identified a single atypical CHS patient. Flow cytometry correctly predicted all 29 patients with FHL-2, XLP1 or 2. Among 85 patients with defective NK degranulation (including 13 asymptomatic siblings), 70 were Sanger sequenced resulting in a genetic diagnosis in 55 (79%). Eight patients underwent WES, revealing mutations in two known and one unknown cytotoxicity genes and one metabolic disease. FHL3 was the most frequent genetic diagnosis. Immunological screening provided an excellent decision tool for the need and depth of genetic analysis of HLH patients and provided functionally relevant information for rapid patient classification, contributing to a significant reduction in the time from diagnosis to transplantation in recent years.

Keywords: Hemophagocytic lymphohistocytosis; degranulation; diagnosis; flow cytometry; whole exome sequencing.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cytometry B Clin Cytom. 2014 Jul;86(4):263-71 - PubMed
    1. Am J Hum Genet. 2009 Oct;85(4):482-92 - PubMed
    1. Blood. 2015 Oct 8;126(15):1858-60 - PubMed
    1. Orphanet J Rare Dis. 2013 Oct 17;8:168 - PubMed
    1. Nat Med. 2005 Mar;11(3):340-5 - PubMed

MeSH terms

LinkOut - more resources